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Abstract 1 
Background: The evidence associating diet and risk of multiple sclerosis (MS) is 2 
inconclusive. 3 
Objectives: We investigated associations between a Mediterranean diet and risk of a 4 
first clinical diagnosis of central nervous system demyelination (FCD), a common 5 
precursor to MS. 6 
Methods: We used data from the 2003-2006 Ausimmune Study, an Australian 7 
multicenter, case-control study examining environmental risk factors for FCD, with 8 
participants matched on age, sex and study region (282 cases, 558 controls; 18-59 years 9 
old; 78% female). The alternate Mediterranean diet score (aMED) was calculated using 10 
data from a food frequency questionnaire. We created a modified version of the aMED 11 
(aMED-Red) where approximately one daily serving (65 g) of unprocessed red meat 12 
received one point. All other components remained the same as aMED. Conditional 13 
logistic regression (254 cases, 451 controls) was used to test associations between 14 
aMED and aMED-Red scores and categories and risk of FCD, adjusting for history of 15 
infectious mononucleosis, serum 25-hydroxyvitamin D concentrations, smoking, 16 
education, total energy intake and dietary under-reporting.  17 
Results: There was no statistically significant association between aMED and risk of 18 
FCD (per one SD increase in aMED score: adjusted odds ratio (aOR):0.89; 95% 19 
confidence interval (CI):0.75,1.06; P=0.181). There was evidence of a non-linear 20 
relationship between aMED-Red and risk of FCD using a quadratic term (P=0.016). 21 
Compared with the lowest category of aMED-Red, higher categories were significantly 22 
associated with reduced risk of FCD, corresponding to a 37% (aOR:0.63; 95% 23 
CI:0.41,0.98; P=0.039), 52% (aOR:0.48; 95% CI:0.28,0.83; P=0.009) and 42% 24 
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(aOR:0.58; 95% CI:0.35,0.96; P=0.034) reduced risk of FCD in categories two, three 25 
and four, respectively. 26 
Conclusions: A Mediterranean diet, including unprocessed red meat, was associated 27 
with reduced risk of FCD in this Australian adult population. The addition of 28 
unprocessed red meat to a Mediterranean diet may be beneficial for those at high risk of 29 
MS.  30 
 31 
Key Words: Multiple sclerosis, Mediterranean diet, Ausimmune Study, nutrition and 32 
disease 33 
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Introduction  36 
Multiple sclerosis (MS) is a chronic inflammatory and neurodegenerative disease of the 37 
central nervous system (CNS) (1). The disease course typically begins with fully or 38 
partially reversible episodes of neurologic disability, developing after 10 to 20 years to 39 
progressive neurologic deterioration (1). MS is more common in females than males, 40 
and among those with an affected first-degree relative. The incidence of MS is 41 
increasing globally, with a suggested role for environmental risk factors, including low 42 
sun exposure, low vitamin D status, smoking and history of infectious mononucleosis 43 
(2). Poor diet may be a modifiable risk factor for MS onset; however, the evidence is 44 
inconclusive and many studies have assessed single foods or nutrients (3-16), rather 45 
than dietary patterns. The latter captures information about total diet, including the 46 
interactions that may occur between food components (17). 47 
 48 
The traditional Mediterranean diet is known for its health benefits across a variety of 49 
chronic diseases. A recent umbrella review identified 29 meta-analyses investigating the 50 
association between adherence to a Mediterranean diet and 37 different health 51 
outcomes, which included neurodegenerative diseases but not specifically MS (18). The 52 
review supports the hypothesis that greater adherence to a Mediterranean diet reduces 53 
the risk of certain health outcomes, including overall mortality, cardiovascular diseases, 54 
diabetes, overall cancer incidence, Alzheimer’s disease and dementia. To our 55 
knowledge, only one previous study has investigated the association between a 56 
Mediterranean diet and risk of MS. That study was conducted in Iran and reported that 57 
greater adherence was associated with reduced risk of MS, with a 77% reduced risk of 58 
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MS for those in the third tertile of the Mediterranean diet score compared with the first 59 
tertile (adjusted odds ratio (aOR):0.23; 95% CI:0.06,0.89; P-trend=0.04) (13).  60 
 61 
A number of approaches have been proposed to define and measure adherence to a 62 
Mediterranean diet (19-24), all of which consider low intakes of red meat as beneficial. 63 
Indeed, the Mediterranean Diet Foundation suggests that meat/meat products be limited 64 
to <2 servings of red meat/week, <1 servings of processed meat/week and 2 servings of 65 
white meat/week, with serving sizes to be based on frugality and local habits (25). To 66 
put this in an Australian context, a standard serving of meat is defined as 65 g (26). 67 
Similarly, a recently proposed new Mediterranean Diet Italian Pyramid suggests a low 68 
intake of unprocessed and processed meat at 100 g/week and 50 g/week, respectively 69 
(27). However, a review of food intakes in 14 local Mediterranean populations (plus one 70 
study of Greek-Australian migrants living in Australia), spanning 46 years of data 71 
collection (1960-2006), showed that mean intake of meat/meat products was 105 g/day, 72 
(28), which is far higher than the aforementioned recommendations. Furthermore, 73 
median daily energy-adjusted meat consumption was approximately 100 g in elderly 74 
men and women resident in three Greek villages in 1990 (29), and meat consumption 75 
per capita in 2013 exceeded 100 g/day in the Mediterranean region (30). Hence, there is 76 
a discrepancy between actual meat intakes in the Mediterranean region and those 77 
recommended as part of the Mediterranean diet. The role of meat in the Mediterranean 78 
diet has recently been reviewed, with authors suggesting that up to one daily serving of 79 
unprocessed red meat should be considered part of the Mediterranean diet (31).  80 
 81 
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The Ausimmune Study was a multicenter, matched case-control study investigating 82 
environmental risk factors for a first clinical diagnosis of CNS demyelination (FCD), a 83 
common precursor to MS. It is one of the largest, most well-characterized samples of 84 
people with early MS worldwide. We previously found that higher intake of very long 85 
chain omega-3 PUFAs (VLCn3PUFAs) (12), higher unprocessed red meat consumption 86 
(16) and greater adherence to a healthy dietary pattern (15) were associated with 87 
reduced risk of FCD in the Ausimmune Study. To build on this evidence, we tested 88 
associations between a Mediterranean diet and risk of FCD using data from the 89 
Ausimmune Study. We tested the alternate Mediterranean diet score (aMED) (20), a 90 
commonly used measure of adherence to a Mediterranean diet. We also created a 91 
variation of the aMED (which we have named aMED-Red), and tested associations 92 
between aMED-Red and risk of FCD. The aMED-Red considers approximately one 93 
daily serving (65g) of unprocessed red meat to be a healthy component of a 94 
Mediterranean diet. 95 
 96 
Methods  97 
Study population 98 
The Ausimmune Study was conducted during 2003-2006 in four regions of Australia, 99 
namely Brisbane city (latitude 27° South), Newcastle region (33°S), Geelong and the 100 
Western districts of Victoria (37°S), and the island of Tasmania (43°S) (32). The study 101 
design and methodology are reported in detail elsewhere (32). In brief, participants aged 102 
between 18 and 59 years and presenting with a FCD (n=282) were notified to the study 103 
by a range of clinicians. The date of onset and presenting symptoms suggestive of 104 
inflammatory CNS demyelination were confirmed by a neurologist following a full 105 
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history and neurological examination (32). A total of 54% of case participants had >9 106 
lesions at FCD; 46% had nine or fewer lesions (including 9% with no lesions). The date 107 
of the MRI scan preceding diagnosis was used as a proxy for date of the FCD, as these 108 
data were available for most participants. The median time lag from MRI scan to study 109 
interview was 103 days (IQR:153 days), with 116 cases having been interviewed within 110 
90 days of the scan.  111 
 112 
Case participants were diagnosed with CNS demyelination for the first time, within the 113 
study period. The diagnoses included: a classic first demyelinating event (FDE; defined 114 
as a single, first, episode of clinical symptoms suggestive of CNS demyelination; 115 
n=216); a first recognized event, but past history revealed a prior, undiagnosed event, 116 
that, on review was highly suggestive of CNS demyelination (n=48); first presentation 117 
of primary progressive MS (based on neurological assessment on study entry (n=18)). 118 
Control participants (n=558) were randomly selected from the general population via 119 
the Australian Electoral Roll and matched on sex, age (within 2 years) and study region 120 
(32). Up to four controls were matched to each case in order to maximize study power 121 
(32).  122 
 123 
The study was conducted in accordance with the Declaration of Helsinki. Ethics 124 
approval was obtained from the nine Human Research Ethics Committees of the 125 
participating institutions (32). All participants gave written informed consent for the use 126 
of their data. All participant information was anonymized and de-identified prior to 127 
analysis. 128 
 129 
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The current study included participants who provided complete data on dietary intake 130 
and all covariates, and who were part of at least a matched case-control pair. Of the 840 131 
participants (282 cases, 558 controls) in the Ausimmune Study, 791 participants 132 
provided dietary intake data. Of these, 746 participants provided data for all covariates 133 
(missing data were serum 25-hydroxyvitamin D (25(OH)D) concentrations, n=38; 134 
history of infectious mononucleosis, n=1; eduation, n=1; smoking history, n=2; and 135 
dietary under-reporting, n=3). Of these, 705 (254 cases, 451 controls) participants were 136 
part of at least a matched pair and thus formed the study cohort for this analysis.  137 
 138 
Dietary assessment 139 
The Cancer Council Victoria Dietary Questionnaire for Epidemiological Studies version 140 
2 (DQESv2) was used to collect information on habitual dietary intakes in the 12 141 
months prior to the study interview. The DQESv2 is a self-administered, semi-142 
quantitative, FFQ designed for use in the ethnically-diverse adult Australian population; 143 
the development of the DQESv2 has been outlined elsewhere (33). The questionnaire 144 
has been validated relative to seven-day weighed food records in 63 women of child-145 
bearing age, where it performed as well as other validated FFQs: mean intakes from the 146 
weighted food record and the DQES were within ±20% for 21 of 27 nutrients (34). 147 
 148 
The DQESv2 included portion size diagrams and measured consumption of food items 149 
from four groups: 1) cereals, sweets and snacks; 2) dairy, meats and fish; 3) fruit; 4) 150 
vegetables. Consumption frequencies of food and drink items were recorded on a scale 151 
from ‘never’ to ‘three or more times a day’. Consumption of alcoholic beverages was 152 
recorded as the total number of glasses usually consumed per day, and the maximum 153 
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number of glasses drunk in any 24 hours. Intake of 101 food and beverage items were 154 
reported in grams per day. Nutrient intakes were computed primarily using composition 155 
data from the Australian NUTTAB 95 database (35).  156 
 157 
Score calculation 158 
We calculated the aMED, proposed by Fung and colleagues (20) as an adaptation of the 159 
nine-point Mediterranean diet score developed by Trichopoulou and colleagues (19). 160 
We created a variation of the aMED in order to include moderate consumption of 161 
unprocessed red meat (defined as beef, lamb, pork and veal) as a healthy component of 162 
a Mediterranean diet (aMED-Red). For the aMED, one point is assigned for intakes 163 
(g/day) of unprocessed and processed red meat (g/day) below the sex-specific median 164 
(20). For the aMED-Red, we modified the meat component of the aMED such that one 165 
point was assigned to intakes of approximately one daily serving (65 g) (26) of 166 
unprocessed red meat (between 0.5 and 1 servings/day; 32.5 and 97.5 g/day) 167 
(Supplemental Table 1). Other components remained the same as the aMED; hence, 168 
the scores for both the aMED and aMED-Red ranged between 0 and 9. Components, 169 
scoring criteria and scoring cut-off points (including sex-specific medians for control 170 
participants) for the aMED and the aMED-Red are described in Supplemental Table 1.  171 
 172 
Some studies use energy-standardized component intakes in the computation of the 173 
aMED score (aMED-e) (36). Hence, we calculated energy-adjusted scores (aMED-e 174 
and aMED-Red-e) where component scores for fruit, vegetables, legumes, nuts, 175 
wholegrains, fish, and red and processed meat (aMED-e only) were based on intake 176 
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standardised to 2500 kcal/day in men and 2000 kcal/day in women, as previously 177 
described (36). 178 
 179 
The total score for the aMED, aMED-Red, aMED-e and aMED-Red-e was calculated as 180 
the sum of all component scores and ranged between 0 and 9 (with 9 indicating the 181 
highest adherence to a Mediterranean diet). Four categories for the aMED, aMED-Red, 182 
aMED-e and aMED-Red-e were created as follows: category 1 (scores 0-2); category 2 183 
(scores 3-4); category 3 (score 5); category 4 (scores 6-9). 184 
 185 
Covariates 186 
Self-report questionnaires were used to collect information on history of infectious 187 
mononucleosis, highest level of education and smoking history (total number of years 188 
smoked minus any periods of abstinence). The study nurse measured height and weight, 189 
and BMI was calculated as weight in kilograms divided by height in metres squared. 190 
Basal metabolic rate was calculated using the equations developed by Harris and 191 
Benedict (37). Under-reporters were classified using the Goldberg cut-off point of 192 
below basal metabolic rate x 1.05 (38). A two-category variable was created for dietary 193 
misreporting: under-reporter and plausible reporter. 194 
 195 
Most participants (94%) provided a blood sample for measurement of serum 25(OH)D 196 
concentrations (since low vitamin D status is a known risk factor for MS (2)). Serum 197 
aliquots (1 mL) were stored at -80°C and analysed for serum 25(OH)D concentrations 198 
using liquid chromatography tandem mass spectrometry (39). To account for blood 199 
samples of cases and controls being taken at different times of the year, serum 25(OH)D 200 
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concentrations for control participants were statistically adjusted to match the date of 201 
the case blood draw, using region-specific seasonal patterns of 25(OH)D concentrations 202 
(39).  203 
 204 
Statistical analysis 205 
Characteristics of participants were described as percentage and frequency for 206 
categorical variables, mean and SD for continuous variables with a Normal distribution, 207 
and median and IQR for continuous variables with a non-Normal distribution. For each 208 
of the nine components of the aMED and aMED-Red, we described the percentage of 209 
case and control participants scoring ‘1’ for the component.   210 
 211 
We used conditional logistic regression, with participants matched on age, sex and 212 
study region, to estimate OR, aOR, 95%CI and P for associations between aMED and 213 
aMED-Red categories and risk of FCD. We tested for non-linearity using a quadratic 214 
term for aMED and aMED-Red as the continuous variable divided by its standard 215 
deviation. Where linearity was indicated, we also reported associations for the 216 
continuous variable. 217 
 218 
Models were run unadjusted and adjusted for history of infectious mononucleosis, 219 
serum 25-hydroxyvitamin D concentration, total years of smoking, education, total 220 
energy intake, and dietary misreporting. Adjustment variables were selected on the basis 221 
of: 1) being a known risk factor for MS (history of infectious mononucleosis, serum 25-222 
hydroxyvitamin D concentrations, smoking); 2) being a possible risk factor for MS 223 
(education); and 3) accounting for the well-documented under-reporting of energy 224 
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intake by self-reported dietary methods (dietary misreporting) (40); and 4) accounting 225 
for total energy intake. We investigated possible interactions between sex and diet 226 
scores using a multiplicative term in adjusted models with a likelihood ratio test. 227 
 228 
We investigated the importance of individual components of aMED and aMED-Red by 229 
further conducting conditional logistic regression models including all individual 230 
components in the same model (unadjusted and adjusted as above). For statistically 231 
significant components, we performed additional models with the individual component 232 
only (unadjusted and adjusted as above). 233 
 234 
We conducted the following sensitivity analyses: a) excluding participants with 235 
implausible energy intakes (<3,000 or >20,000 kJ/day) (41) (n=684, 249 cases, 435 236 
controls) and b) including only case participants with a classic FDE (n=535, 195 cases, 237 
340 controls). To investigate any differences between raw and energy-adjusted 238 
components in associations with risk of FCD, we ran additional conditional logistic 239 
regression models using aMED-e and aMED-Red-e as per the main models (although 240 
models were not adjusted for total energy intake), and we tested for non-linearity and 241 
possible interactions between sex and diet scores.  Data were analyzed using Stata 14 242 
software (42). Statistical significance was defined as P < 0.05. 243 
 244 
Results  245 
Case participants were more likely than controls to have a history of infectious 246 
mononucleosis, lower serum 25(OH)D concentrations, and to have completed education 247 
beyond year 10 (Table 1). The majority of participants scored between 2 and 6 on both 248 
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aMED and aMED-Red (Figure 1). Compared with control participants, there was a 249 
lower percentage of case participants with a score of 1 vs. 0 on healthy components of 250 
vegetables, legumes, wholegrains, fish and MUFA:SFA, and a higher percentage 251 
scoring 1 on fruit (Supplemental Table 2). Compared with control participants, there 252 
was a lower percentage of case participants scoring 1 for unprocessed red meat (where 253 
1=approximately one daily serving of 65 g), and a higher percentage of case participants 254 
scoring 1 for red meat (unprocessed and processed) below the sex-specific median of 255 
control participants.  256 
 257 
Quadratic terms indicated no evidence of a non-linear relationship between aMED and 258 
risk of FCD, but evidence of a non-linear relationship between aMED-Red and risk of 259 
FCD (P=0.016). Hence, we did not run models with aMED-Red as the continuous 260 
variable. There were no statistically significant associations between aMED and risk of 261 
FCD (Supplemental Table 3). Compared with the lowest category of aMED-Red, 262 
higher categories were statistically significantly associated with reduced risk of FCD, 263 
corresponding to a 37% (aOR:0.63, 95% CI:0.41,0.98; P=0.039), 52% (aOR:0.48, 95% 264 
CI:0.28,0.83; P=0.009) and 42% (aOR:0.58; 95% CI:0.35,0.96; P=0.034) reduced risk 265 
of FCD in categories two, three and four, respectively (Figure 2). For both aMED and 266 
aMED-Red, there was no evidence of an interaction with sex (P-interaction > 0.1). 267 
Similar findings were observed in the sensitivity analyses of those with plausible energy 268 
intakes and in the classic FDE group (Supplemental Table 4), and when using energy-269 
adjusted components (Supplemental Table 5). 270 
 271 
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When included together in a single model, no individual components of aMED were 272 
statistically significantly associated with risk of FCD (Table 2). However, of the 273 
aMED-Red components, a score of 1 compared with a score of 0 for unprocessed red 274 
meat was significantly associated with reduced risk of FCD in models adjusted for all 275 
other components and potential confounders (Table 2). In a model adjusted for potential 276 
confounders, but excluding the other aMED-Red components, the odds ratio for a score 277 
of 1 compared with a score of 0 for the unprocessed red meat component and risk of 278 
FCD was similar, albeit of borderline statistical significance (aOR:0.72; 95% 279 
CI:0.52,1.00; P=0.053). 280 
 281 
Discussion 282 
Our results support an association between greater adherence to a Mediterranean diet 283 
that includes unprocessed red meat and reduced risk of FCD. Compared with the lowest 284 
category, the three higher categories were associated with reduced risk of FCD, 285 
although the association was non-linear, with the lowest odds ratio seen in category 286 
three compared with category one. Our results suggest that scoring between one and 287 
two (category one) on the aMED-Red should be avoided if these estimates represent 288 
causal effects, with insufficient evidence to differentiate the benefits of being in the 289 
higher categories. Using a common scoring system for the Mediterranean diet (aMED), 290 
which emphasizes low red meat (unprocessed and processed) consumption, we did not 291 
observe any statistically significant associations with risk of FCD. Indeed, the 292 
unprocessed red meat consumption component of the aMED-Red was the only 293 
component to associate independently with risk of FCD. This supports our recent 294 
findings that higher consumption of unprocessed red meat was associated with reduced 295 
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risk of FCD in the Ausimmune Study (16). The new findings presented here highlight 296 
the importance of unprocessed red meat as part of a healthy Mediterranean diet and 297 
association with reduced risk of FCD. 298 
 299 
Our findings support previous studies investigating dietary patterns and risk of MS (13, 300 
14). A hospital-based case control study in Iran showed that a higher Mediterranean diet 301 
score was associated with reduced risk of MS (13). Similar to our study, the score used 302 
to measure adherence to a Mediterranean diet in that study did not emphasize low red 303 
meat consumption; rather, a lower ratio of red meat to white meat was considered 304 
beneficial. The typical Iranian diet is characterized in part by high red meat and organ 305 
meat consumption (14); hence, overall red meat consumption was likely to be high in 306 
that population. Indeed, a further study in the Iranian population showed that higher 307 
adherence to a traditional Iranian dietary pattern (high in low-fat dairy products, red 308 
meat, vegetable oil, onion, whole grain, soy, refined grains, organ meats, coffee, and 309 
legumes) was associated with reduced risk of MS (14). 310 
 311 
Red meat contains important macro- and micronutrients, including protein, iron, zinc, 312 
selenium, potassium, vitamin D (43), a range of B-vitamins and, for grass-fed beef, 313 
VLCn3PUFAs (44-46). Many of these nutrients are important for healthy neurological 314 
function, and low levels of vitamin D (2, 39), VLCn3PUFAs (12, 47) and iron (48) have 315 
been associated with increased risk and/or progression of MS. Indeed, in previous 316 
analysis of the Ausimmune Study, we found that higher intake of VLCn3PUFAs, such 317 
as those found in fish and meat, was associated with reduced risk of FCD, but not 318 
higher intake of alpha-linolenic acid, found in some plant-based foods (12). It has also 319 
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been suggested that iron sufficiency may be important in preventing MS since iron is 320 
involved in the synthesis, maintenance and repair of myelin, may be critical to 321 
oligodendrocyte activity and integrity, and plays an integral role in mitochondrial 322 
energy production (49). Unprocessed red meat is high in heme iron (50), which is more 323 
bioavailable than the plant form of iron (non-heme) (51). A study in older Australian 324 
adults showed that restricting red meat was one of the most difficult aspects of adhering 325 
to a Mediterranean diet over a six-month dietary intervention (52), which may affect the 326 
long-term sustainability of the diet (53). Hence, encouraging restriction of red meat to 327 
<3 servings/week (as suggested by the Mediterranean Diet Foundation (25)) may be 328 
unnecessary and difficult to follow and, according to our findings, may be detrimental 329 
to those at high risk of FCD. 330 
 331 
A recent randomized, crossover, controlled feeding trial showed that adopting a 332 
Mediterranean-style diet, with or without reduction in red meat intake, improved 333 
multiple cardiometabolic risk factors in overweight or moderately obese adults (54). 334 
Authors concluded that adults who are overweight or obese can consume approximately 335 
70 g/day of lean, unprocessed red meat without adversely affecting cardiometabolic 336 
health. A further randomized controlled trial is underway to assess the inclusion of pork 337 
in the Mediterranean diet and subsequent effects on cardiovascular risk and cognitive 338 
function, with authors hypothesizing that pork may be an appropriate addition to the 339 
Mediterranean diet (53). In light of the current interest in unprocessed red meat as part 340 
of the Mediterranean diet, the aMED-Red score may be worthy of investigation in 341 
epidemiological analysis of other health outcomes beyond MS. 342 
 343 
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Other epidemiologic research in relation to diet and risk of MS has been conducted in 344 
individuals who have established MS, making reverse causation (i.e. that the diagnosis 345 
led to behavior changes in dietary intake) a potential limitation of those studies. A major 346 
strength of the Ausimmune Study was that collection of dietary data was soon after the 347 
FCD, rather than in people with established MS. However, we acknowledge that 348 
prodromal symptoms, such as fatigue and depression (55-57), may lead to differences in 349 
eating habits in the years prior to FCD; therefore, we cannot rule out the possibility of 350 
reverse causation. 351 
 352 
As with all studies using self-reported dietary assessment methods, a limitation of our 353 
study is the widely acknowledged under-reporting of energy intake (40). We attempted 354 
to account for dietary under-reporting by including a misreporting variable in adjusted 355 
models. Cases may be more likely to recall exposure to risk factors than controls (58).	356 
However, we believe this bias to be minimal in our study since diet is not commonly 357 
considered a cause of CNS demyelination. Moreover, if the recall of unhealthy food 358 
intake and portion sizes for the FCD cases was systematically greater than for controls, 359 
this would imply that FCD cases would recall a greater intake and portion sizes of 360 
unprocessed red meat, since red meat is often considered part of a "Western" 361 
(unhealthy) diet. Such recall bias would likely result in attenuation of the OR for the 362 
association between unprocessed red meat and FCD. Therefore, our results provide a 363 
conservative estimate of the association between aMED-Red and risk of FCD. Typical 364 
of any epidemiological analysis, we cannot rule out the potential of residual 365 
confounding where other unmeasured lifestyle characteristics may influence the 366 
relationship between dietary intake and risk of FCD. However, with the exception of 367 
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smoking, most lifestyle characteristics - including BMI, alcohol intake and physical 368 
activity - were not associated with risk of FCD in previous analyses of data from the 369 
Ausimmune Study (59). Finally, our study population was predominantly female and 370 
Caucasian, with participants likely to be consuming a typical Australian diet. 371 
Investigating associations between a Mediterranean diet and risk of FCD or MS in a 372 
multi-ethnic population would allow greater generalizability of results.  373 
 374 
Limitations notwithstanding, our results show that a Mediterranean diet that includes 375 
approximately one daily serving of unprocessed red meat (where one serving=65 g) is 376 
associated with lower risk of FCD. Given that the maximum number of weekly servings 377 
of lean red meat recommended for Australian adults is seven (26), such a diet is in line 378 
with recommendations for the general population. The intake of unprocessed red meat 379 
in the Australian adult population is considerably higher than this recommendation - 380 
current median intake for Australian adults aged >18 years is 150 g/day (60). In general, 381 
young Australian women are advised to eat more red meat, while Australian adult males 382 
need to eat less red meat (61). Healthy eating guidelines designed for the general 383 
population are currently the best available dietary recommendations for people at high 384 
risk of MS; however, less than 4% of the Australian population follow the Australian 385 
Dietary Guidelines (26). Hence, improved nutrition education for people at high risk of 386 
MS may be beneficial for their general health as well as reducing their risk of FCD, or 387 
of MS.  388 
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Table 1. Characteristics of participants with FCD and matched controls 
 
  Case  (n=254) 
Control 
(n=451) 
Sex2   
   Male 64 (25.2) 109 (24.2) 
   Female  190 (74.8) 342 (75.8) 
Age, years2 38.6 ± 9.7 40.0 ± 9.6  
Study region2   
   Brisbane (27°S) 86 (33.9) 167 (37.0) 
   Newcastle (33°S) 32 (12.6) 66 (14.6) 
   Geelong (37°S) 60 (23.6) 111 (24.6) 
   Tasmania (43°S) 76 (29.9) 107 (23.7) 
History of infectious mononucleosis    
   No  166 (65.4) 356 (78.9) 
   Yes  70 (27.6) 73 (16.2) 
   Don’t know  18 (7.1) 22 (4.9) 
Serum 25(OH)D concentrations (nmol/L) 75.7 ± 29.6 81.9 ± 30.6 
Total years of smoking 5.4 [18.6] 2.0 [15.0] 
Education   
   Year 10 or less 63 (24.8) 150 (33.3) 
   Year 12 and TAFE  126 (49.6) 188 (41.7) 
   University 65 (25.6) 113 (25.1) 
Dietary misreporting   
   Under-reporter 107 (42.1) 182 (40.4) 
   Plausible/over-reporter 147 (57.9) 269 (59.6) 
Total energy intake (kcal/day) 1673 [905] 1730 [883] 
aMED category 
     Category 1 (scores 0-2) 61 (24.0) 90 (20.0) 
   Category 2 (scores 3-4) 87 (34.3) 165 (36.6) 
   Category 3 (score 5) 52 (20.5) 82 (18.2) 
   Category 4 (scores 6-9) 54 (21.3) 114 (25.3) 
aMED-Red category 
     Category 1 (scores 0-2) 75 (29.5) 87 (19.3) 
   Category 2 (scores 3-4) 81 (31.9) 156 (34.6) 
   Category 3 (score 5) 43 (16.9) 96 (21.3) 
   Category 4 (scores 6-9) 55 (21.7) 112 (24.8) 
1Values are frequencies (percentages), means ± SDs, or medians [IQRs] 
2Case and control participants were matched for sex, age (within 2 years) and study 
region 
25(OH)D, 25-hydroxyvitamin D; aMED, alternate Mediterranean diet score; aMED-
Red, alternative Mediterranean diet score with unprocessed red meat; FCD, first clinical 
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diagnosis of central nervous system demyelination; TAFE, Technical And Further 
Education
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Table 2. aORs, 95% CIs and P for components of the aMED and aMED-Red (for scoring 1 vs. 0 on the component) and risk of FCD (254 
cases, 451 controls) 
  Unadjusted for covariates1   Adjusted for covariates2 
  aOR (95% CI) P   aOR (95% CI) P 
aMED      
   Fruit 1.36 (0.95, 1.95) 0.09  1.41 (0.96, 2.06) 0.08 
   Vegetables 0.86 (0.61, 1.19) 0.36  0.88 (0.61, 1.25) 0.47 
   Legumes 0.77 (0.55, 1.07) 0.12  0.72 (0.50, 1.02) 0.07 
   Nuts 1.13 (0.79, 1.60) 0.51  1.18 (0.81, 1.70) 0.39 
   Wholegrains 0.77 (0.54, 1.08) 0.13  0.73 (0.50, 1.05) 0.09 
   Fish 0.78 (0.56, 1.08) 0.13  0.74 (0.52, 1.05) 0.09 
   Red and processed meat 1.31 (0.96, 1.81) 0.09  1.38 (0.93, 2.02) 0.11 
   MUFA:SFA 0.91 (0.66, 1.26) 0.58  0.86 (0.61, 1.23) 0.41 
   Alcohol 1.03 (0.69, 1.54) 0.89  1.01 (0.66, 1.55) 0.96 
aMED-Red      
   Fruit 1.35 (0.94, 1.93) 0.10  1.40 (0.96, 2.06) 0.08 
   Vegetables 0.81 (0.58, 1.13) 0.21  0.86 (0.60, 1.24) 0.42 
   Legumes 0.76 (0.54, 1.06) 0.11  0.71 (0.50, 1.01) 0.06 
   Nuts 1.16 (0.82, 1.66) 0.40  1.23 (0.85, 1.78) 0.28 
   Wholegrains 0.77 (0.55, 1.09) 0.15 
 
0.74 (0.51, 1.07) 0.11 
   Fish 0.76 (0.54, 1.05) 0.10 
 
0.75 (0.53, 1.07) 0.11 
   Unprocessed red meat 0.67 (0.49, 0.93) 0.02 
 
0.70 (0.50, 0.97) 0.03 
   MUFA:SFA 0.92 (0.66, 1.29) 0.63 
 
0.85 (0.59, 1.21) 0.36 
   Alcohol 1.07 (0.71, 1.60) 0.76 		 1.01 (0.66, 1.55) 0.96 
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1All components included in one model for aMED and one model for aMED-Red, not adjusted for covariates; 2All components included in 
one model for aMED and one model for aMED-Red, and further adjusted for history of infectious mononucleosis, serum 25-
hydroxyvitamin D concentrations, total years of smoking, education, total energy intake and dietary under-reporting 
aMED, alternate Mediterranean diet score; aMED-Red, alternative Mediterranean diet score with unprocessed red meat; aOR, adjusted 
odds ratio; FCD, first clinical diagnosis of central nervous system demyelination 
 	
Figure 1. Distribution of aMED (A) and aMED-Red scores (B) in adults with FCD (n=254) 
and matched controls (n=451) 
aMED, alternate Mediterranean diet score; aMED-Red, alternate Mediterranean diet score 
with unprocessed red meat; FCD, first clinical diagnosis of central nervous system 
demyelination 
 
Figure 2. OR, aOR1 and 95% CI of categories of aMED-Red and risk of FCD (254 cases, 451 
controls) 
1Adjusted for history of infectious mononucleosis, serum 25-hydroxyvitamin D 
concentrations, total years of smoking, education, total energy intake and dietary under-
reporting 
aMED-Red, alternate Mediterranean diet score with unprocessed red meat; aOR, adjusted 
odds ratio; FCD, first clinical diagnosis of central nervous system demyelination 
 
	
	
